首页 › 基金 › GLENVIEW CAPITAL MANAGEMENT, LLC › BSX
GLENVIEW CAPITAL MANAGEMENT, LLC 对 BSX 的持仓历史
BOSTON SCIENTIFIC CORP · 医疗保健
GLENVIEW CAPITAL MANAGEMENT, LLC 在 Q2 2026 的 13F 申报中披露持有 BSX(BOSTON SCIENTIFIC CORP)113,096 股,市值约 US$4.8M,约占其申报组合的 0.09%,在其申报持仓中市值排名第 42 位。 GLENVIEW CAPITAL MANAGEMENT, LLC 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
GLENVIEW CAPITAL MANAGEMENT, LLC 对 BSX 的持仓演变
GLENVIEW CAPITAL MANAGEMENT, LLC 于 Q2 2026 首次披露 BSX 持仓:113,096 股(约 US$4.8M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 113.10K | $4.83M | 新进 |
关于 BSX 与 13F 数据
BSX(BOSTON SCIENTIFIC CORP)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 BSX,申报仓位最大的包括:Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), 德劭基金 (US$1.16B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BSX 的基金
- Banque Cantonale Vaudoise 67.61K 股 · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M 股 · $2.16B · Q2 2026
- 德劭基金 27.27M 股 · $1.16B · Q2 2026
- 骏利亨德森集团 16.50M 股 · $1.04B · Q1 2026
- Arrowstreet 资本 23.29M 股 · $994.18M · Q2 2026
- Bollard Group LLC 18.42M 股 · $786.20M · Q2 2026
更多关于 GLENVIEW CAPITAL MANAGEMENT, LLC
常见问题
How long has GLENVIEW CAPITAL MANAGEMENT, LLC held BSX?
GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed BSX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in BSX?
As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 113.10K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $4.83M, representing 0.09% of its reported portfolio and ranking #42.
Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling BSX?
In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC newly opened its position in BSX.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, 德劭基金, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.